Polskie Radio covers newer weight loss drugs said to outperform Ozempic. The material doesn't name the drugs or the data behind the claim.
Recap by typeshit. Full story at www.polskieradio.pl.
Researchers found the peptide they built as a treatment already circulates in human blood, at lower levels in people with cognitive impairment.
Topol points to work suggesting the body's own GLP-1 family peptides help reduce inflammation in the gut. Details are thin, so tap through for the study.
Medscape explores whether GLP-1 medicines might help keep people with schizophrenia out of the hospital. Tap through for the evidence behind the idea.
The weight loss drug class started with a lizard. A short local feature looks at how the Gila monster led researchers to GLP-1 medicines.
26:51
A full day of low carb, high protein eating from Roseland Lashay as she shifts into maintenance on tirzepatide.
19:08
A physician on YouTube makes the case that GLP-1 drugs like Ozempic and Mounjaro, plus trial drug retatrutide, are misunderstood when framed as weight loss drugs.
Loading…